Abstract:AIM: The need for non-parenteral administration of inactivated avian influenza virus of H5N1 subtype (AIV-H5N1) vaccine is paramount. Here, we provide preliminary data on the immune response of chicken and mice after intranasal administration of AIV-H5N1-inactivated vaccine with ISCOMS, Inmunair (INM), and combined ISCOMS and INM as an adjuvant.MATERIALS AND METHODS: The AIV isolate of A/Chicken/Denpasar/01/2004 (H5N1) was cultivated in specific pathogen-free chicken eggs and inactivated with formaldehyde. The vaccine preparation was added with those adjuvants for intranasal administration and aluminum hydroxide for subcutaneous injection. The chicken and mouse were vaccinated at the age of 3 weeks or 1 month and repeated 2 weeks thereafter. In one experiment, chicken was injected with Newcastle disease virus (NDV) at the same time with AIV vaccine. The sera were collected at one (serum 1) and 2 w (serum 2) after booster vaccination. The anti-AIV-H5 and NDV antibodies in chicken sera were detected using hemagglutination inhibition (HI) assay. Mouse IgG anti-AIV-H5N1 antibody was detected using ELISA.RESULTS: The result shows that the geometric mean titers (GMTs) of chicken sera of intranasal vaccinated with inactivated AIV-H5N1 vaccine with mixed ISCOM- INM as adjuvant were <20.0 and 22.7 unit HI-unit (HIU) in serum 1 and serum 2, respectively. The GMTs of the positive control group were 23.7 and 25.7 HIU in serum 1 and serum 2, respectively. The result of the second experiment shows that IgG anti-AIV-H5N1 was detected in mouse sera. In the third experiment, the GMTs of anti-NDV in chicken vaccinated subsequently with inactivated NDV vaccine and AIV-H5N1 with mixed ISCOMS-INM administrated intranasally and aluminum hydroxide adjuvant administrated through subcutaneous injection as well as positive control group receiving NDV vaccine only were 28.0, 28.0, and 27.4 HIU in serum 1 while were 29.6, 29.2, and 28.2 HIU in serum 2, respectively.CONCLUSION: Intranasal administration of inactivated AIV-H5N1 vaccine-induced a systemic immune response in chicken and mice after adding ISCOMS and/or INM as adjuvants. The adjuvant and the intranasal administration caused no immunosuppressive effect on the chicken immune response to NDV vaccine.

Co-administration with Inactivated Avian Influenza Virus and Adjuvants Enhances the Antibody Secreting Cells in Duck Respiratory Tract

Effect of intranasal immunization with inactivated avian influenza virus on local and systemic immune responses in ducks.

Effects of intranasal immunization with inactivated avian influenza virus in combination with adjuvants on the antibody secreting cells in pigeon respiratory tract

A novel combined adjuvant strongly enhances mucosal and systemic immunity to low pathogenic avian influenza after oral immunization in ducks.

Effect of Intranasal Immunization with Inactivated Avian Influenza Virus and Adjuvant on the Antibody Secreting Cells in Chicken Respiratory Tract

Effect of oral immunization with inactivated avian influenza virus and adjuvant on the antibody secreting cells in duck digestive tract

Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken.

Enhancement of the Immunogenicity of DNA Vaccine Against Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin 2.

Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck

Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken.

IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.

Administration of Infectious Bursal Disease Vaccine in Houhai Acupoint Promotes Robust Immune Responses in Chickens.

The preliminary screening of different adjuvants in transcutaneous immuniza-tion with inactivated human highly pathogenic avian influenza vaccine

Improved cellular immune response induced by intranasal boost immunization with chitosan coated DNA vaccine against H9N2 influenza virus challenge

Immunity response induced by intranasal immunization with inactived human high pathogenic avian influenza vaccine

Induction of IgA, IgM and IgG Antibodies in Ducklings Immunized With Attenuated Duck Plague Virus Vaccine Strain

Intranasal administration of inactivated avian influenza virus of H5N1 subtype vaccine-induced systemic immune response in chicken and mice

Effects of Intranasal Immunization with Attenuated Mycoplasma Hyopneumoniae Strain in Combination with Adjuvant on the Antibody Secreting Cells in Pig Respiratory Tract

Effects of Different CpG Oligodeoxynucleotides with Inactivated Avian H5N1 Influenza Virus on Mucosal Immunity of Chickens.

Interleukin 8 Enhances the Immune Response of Ducks to Avian Influenza Vaccine

Polysaccharide from Atractylodes macrocephala Koidz Binding with Zinc Oxide Nanoparticles as a Novel Mucosal Immune Adjuvant for H9N2 Inactivated Vaccine